Nella Pignatelli was only 22-years-old when she was diagnosed with B-cell acute leukemia. She had to undergo grueling ...

Running the Boston Marathon the same year as your mother and brothers is the chance of a lifetime.But sometimes, it’s more ...

The FDA granted a positive review for an acute myeloid leukemia drug trial, with initial dosing expected in 2025.

Thumbs up for Joel’ is a dedicated fund at The Children and Young People's Cancer Association, raising money for research ...

Researchers from The University of Osaka identify a molecule that can support specific therapeutic targeting of AML with ...

An athletic 33-year-old given months to live after her leukaemia was initially mistaken for long Covid has said one doctor ...

Ziftomenib’s FDA application for relapsed/refractory NPM1-mutant acute myeloid leukemia is supported by data from the ...

Inotuzumab ozogamicin is safe and effective in adult patients with relapsed/refractory B-cell acute lymphoblastic leukaemia, ...

Mid Valley High School graduate Eddie Kaufman has always been a team player, whether on the baseball field or the golf course ...

Thanks to Make-A-Wish Malaysia and the armed forces, cancer patient Akif Ziyan Azhar had his dream fulfilled of experiencing ...

Drug-carrying DNA aptamers can deliver a one-two punch to leukemia by precisely targeting the elusive cancer stem cells that ...

In March 2025, Juventas Cell Therapy Ltd. conducted a phase Ib/II trial to evaluate the safety and efficacy of CNCT19 ...